Mangoceuticals MGRX
NASDAQ MGRX
$0.44 +0.06 (+15.51%)
At close: Sep 29, 2026 · 4:00 PM EDT

Mangoceuticals (MGRX) EPS (Diluted) (2023 - 2026)

Updated

Mangoceuticals (MGRX) reported EPS (Diluted) of -$0.09 for Q2 2026, compared with -$0.57 a year earlier.

Analysis

Mangoceuticals (MGRX) EPS (Diluted) (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Mangoceuticals' EPS (Diluted) came in at -$0.95; for FY2025, it was -$2.17.

  • By year, EPS (Diluted) came in at -$4.80 in FY2024 and -$8.58 in FY2023.
  • The Q2 2026 figure ranks as the highest quarterly EPS (Diluted) in data going back to Q1 2023.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$0.22 (Q1 2026), -$0.30 (Q4 2025) and -$0.69 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 HCA Healthcare 94.29 Bn 93.74 Bn - 7.62
2 Natera 59.14 Bn 54.82 Bn 485.19 Mn -0.47
3 Quest Diagnostics 26.23 Bn 24.66 Bn 1.03 Bn 2.86
4 Labcorp Holdings 25.04 Bn 22.81 Bn 1.11 Bn 3.64
5 Guardant Health 23.69 Bn 19.76 Bn 219.03 Mn -0.90
6 Tenet Healthcare 20.77 Bn 11.92 Bn - 9.84
7 Tempus AI 14.91 Bn 11.94 Bn 246.50 Mn 0.03
8 Encompass Health 12.24 Bn 12.70 Bn - 1.54
9 Davita 11.39 Bn 10.15 Bn 1.16 Bn 4.02
10 Mangoceuticals 6.85 Mn 4.47 Mn 44,215.00 -0.09
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.09
Mar 31, 2026 -0.22
Dec 31, 2025 -0.30
Sep 30, 2025 -0.69
Jun 30, 2025 -0.57
Mar 31, 2025 -1.12
Dec 31, 2024 -0.98
Sep 30, 2024 -1.14
Jun 30, 2024 -1.37
Mar 31, 2024 -1.56
Dec 31, 2023 -2.39
Sep 30, 2023 -1.70
Jun 30, 2023 -2.17
Mar 31, 2023 -3.41
API Access

Mangoceuticals EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=MGRX&period=max&api_key=YOUR_API_KEY